EUVIMEDEUVIMED entdecken
Crossref

Pyroptosis‐related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma

Yi Zhang, Yuzhi Wang, Jiamiao Weng, Jianlin Chen, Yue Zheng, Yu Xia, Zhixin Huang, Lilan Zhao, Xiongfeng Chen, Haijun Tang, Yi Huang

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Yi Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Lung Neoplasms, Proto-Oncogene Proteins c-akt, Pyroptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Medical Vertical Project of Fujian Province, Key Project of Natural Science Foundation of Fujian province, Joint fund of science and technology innovation of Fujian province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung squamous cell carcinoma (LUSC) is one of the most common malignant tumors of the respiratory. Pyroptosis plays an essential role in cancer, but there is limited research investigating pyroptosis in LUSC. In this study, pyroptosis‐related genes were observed to have extensive multiomics alterations in LUSC through analysis of the TCGA database. Utilizing machine learning for selection and verifying expression levels, GSDMC was chosen as the critical gene for further experiments. Our research found that GSDMC is overexpressed in LUSC tissues and cells, and is associated with poor prognosis. Knockdown of GSDMC in LUSC inhibits cell proliferation, invasion, metastasis, chemotherapeutic sensitivity, and reduced tumor formation in nude mice, accompanied by downregulation of proliferative and EMT‐related protein expression. However, these effects were counteracted in cells where GSDMC is overexpressed. Mechanistically, the oncogenic role of GSDMC is primarily achieved through the activation of the AKT/mTOR pathway, and this effect can be significantly reversed by rapamycin. Finally, SMAD4's interaction with the promoter region of GSDMC results in the suppression of GSDMC expression. In summary, our study through bioinformatics and experimental approaches not only proves that SMAD4 regulates the protumorigenic role of GSDMC through transcriptional targeting, but also indicates the possibility of developing the SMAD4/GSDMC/AKT/mTOR signaling axis as a potential biomarker and treatment target for LUSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesLung NeoplasmsProto-Oncogene Proteins c-aktPyroptosisGene Expression Regulation, NeoplasticCarcinoma, Squamous CellMice, NudeCell ProliferationSignal TransductionHumansAnimalsPrognosisMiceCell Line, TumorDisease ProgressionFemaleMaleSmad4 ProteinBiomarkers, Tumor

Stichwörter der Autor:innen

GSDMCSMAD4lung squamous cell carcinomamTORpyroptosis

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktMTOR protein, humanSmad4 ProteinSMAD4 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Clinical Laboratory, Fujian Provincial Hospital, Fuzhou, Fujian, China.
  • Department of Laboratory Medicine, Deyang People's Hospital, Deyang, Sichuan, China.
  • Integrated Chinese and Western Medicine College, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
  • Department of General Thoracic Surgery, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Scientific Research, Fujian Provincial Hospital, Fuzhou, Fujian, China.

Förderung

  • Medical Vertical Project of Fujian Province
  • Key Project of Natural Science Foundation of Fujian province
  • Joint fund of science and technology innovation of Fujian province

Zitieren

APA

Zhang, Y., Wang, Y., Weng, J., Chen, J., Zheng, Y., Xia, Y., Huang, Z., Zhao, L., Chen, X., Tang, H., & Huang, Y. (2024). Pyroptosis‐related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23805

Vancouver

Zhang Y, Wang Y, Weng J, Chen J, Zheng Y, Xia Y, et al. Pyroptosis‐related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23805

BibTeX
@article{Zhang2024,
  author = {Zhang, Yi and Wang, Yuzhi and Weng, Jiamiao and Chen, Jianlin and Zheng, Yue and Xia, Yu and Huang, Zhixin and Zhao, Lilan and Chen, Xiongfeng and Tang, Haijun and Huang, Yi},
  title = {Pyroptosis‐related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23805}
}
Kostenlos starten →